Hospitals | April 18, 2026
Marengo Asia Hospitals acquires majority stake in Sunshine Global Hospitals
Move strengthens footprint in Western India and expands multi-specialty care network
Move strengthens footprint in Western India and expands multi-specialty care network
The company allocated €56 million to research and development for next-generation line solutions
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
In his new role, Karthik will lead human capital strategy and HR operations across these regions
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
Divestment marks Redcliffe’s strategic pivot toward preventive and advanced diagnostics; Crysta IVF to continue under existing leadership
The acquisition adds VYKAT XR (diazoxide choline), the first FDA-approved therapy for hyperphagia in Prader-Willi syndrome (PWS), a rare genetic disorder, to Neurocrine’s portfolio
The acquisition aims to bolster Merck’s hematology portfolio with Terns’ lead oncology candidate, TERN-701
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Subscribe To Our Newsletter & Stay Updated
